Late-Breaking Abstracts will be considered for the 2020 International Congress if they fulfill the following criteria:
- The topic must be of critical importance to the clinical/scientific community and/or the public.
- The abstract must be report data that became available for public dissemination only after the deadline of the regular abstract submission (March 1, 2020), and has not been previously published or presented.
- The study and results reported should be novel (not simply an extension of previously published work) or be definitive of confirming or refuting other critically important work.
- The following categories are typically suited to the main poster sessions and will not be considered for Late-Breaking Abstracts: case reports, qualitative surveys, reviews of existing treatments, practice reviews, rating scale validation, small confirmatory studies, small scale epidemiology studies, research proposals.
- The Late-Breaking Abstract program is not designed to favor investigators who inadvertently missed the deadline for regular abstract submission.
Please note that even a high-quality abstract may be rejected on the basis of not meeting the full criteria of an MDS Late-Breaking Abstract.
Further details and submission link will be available on this webpage in March 2020.